Stockscreener 앱 받기
0.931
6.62%
-0.066
시간 외 거래:
.97
0.039
+4.19%
전일 마감가:
$0.997
열려 있는:
$0.985
하루 거래량:
62,546
Relative Volume:
0.04
시가총액:
$3.11M
수익:
-
순이익/손실:
$-7.35M
주가수익비율:
-2.45
EPS:
-0.38
순현금흐름:
$-5.48M
1주 성능:
-20.43%
1개월 성능:
-21.76%
6개월 성능:
+132.46%
1년 성능:
+91.96%
1일 변동 폭
$0.89
$1.01
1주일 범위
$0.89
$1.22
52주 변동 폭
$0.2872
$3.30
Shuttle Pharmaceuticals Holdings Inc Stock (SHPH) Company Profile
명칭
Shuttle Pharmaceuticals Holdings Inc
전화
-
주소
-
SHPH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| SHPH | 0.931 | 3.11M | 0 | -7.35M | -5.48M | -0.38 |
| ZTS | 176.42 | 79.51B | 9.15B | 2.43B | 2.31B | 4.92 |
| TAK | 13.53 | 42.89B | 30.27B | 1.93B | 3.45B | 0.444 |
| HLN | 9.43 | 42.57B | 14.26B | 1.55B | 0 | 0.3327 |
| TEVA | 16.49 | 18.51B | 16.77B | -959.00M | 1.37B | -2.00 |
| VTRS | 13.00 | 15.37B | 15.24B | -646.50M | 1.88B | 1.53 |
Shuttle Pharmaceuticals Holdings Inc 주식(SHPH)의 최신 뉴스
500: Something went wrong - Investing.com UK
Shuttle Pharma Provides Third Quarter 2024 Corporate Update - GlobeNewswire
Shuttle Pharma Advances Phase 2 Trial, Secures $4.5M Funding for Cancer Treatment Study | SHPH Stock News - StockTitan
Shuttle Pharmaceuticals’ $4.5 Million Common Stock Offering - Global Legal Chronicle
Top 3 Penny Stocks to Watch Today – October 31, 2024 - The Global Domains News
Shuttle Pharma (SHPH) Stock Surges on Clinical Trial, Financing and Debt Elimination News - MSN
Shuttle Pharma Raises $4.5M for Clinical Trials - TipRanks
3 Penny Stocks to Watch Now, 10/31/24 - TipRanks
Shuttle Pharmaceuticals Successfully Doses First Patients in Phase 2 Clinical Trial for Glioblastoma Treatment - Defense World
Shuttle Pharma doses three subjects in Phase II glioblastoma treatment trial - Yahoo! Voices
"Stocks Key Trendlines: PRSO, PFIE, SHPH, BKYI, LIXT on the Verge of Breakthroughs" - Marketscreener.com
SHPHShuttle Pharmaceuticals Holdings, Inc. Latest Stock News & Market Updates - StockTitan
Shuttle Pharmaceuticals Holdings, Inc. Announces Pricing of - GlobeNewswire
Shuttle Pharmaceuticals Holdings, Inc. Announces Pricing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules - StockTitan
Shuttle Pharmaceuticals Holdings, Inc. Announces Pricing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules - Benzinga
Shuttle Pharma Pays Off Senior Secured Convertible Note - GlobeNewswire
Micro Cap Company Is Soaring On Phase 2 Trial Update - MSN
Micro Cap Soaring On Phase 2 Trial Update - Invezz
TSX American Preferred Stock Index (STNC) QuotePress Release - The Globe and Mail
US Stocks Mixed; McDonald's Posts Upbeat Earnings - Benzinga
Shuttle Pharmaceuticals Advances Phase 2 Glioblastoma Trial - TipRanks
Shuttle Pharma (SHPH) Stock Rises Pre-Market With Completion Site Enrollments - Stocks Telegraph
Shuttle Pharma Doses First Patients in Phase 2 Clinical - GlobeNewswire
Shuttle Pharma Doses First Patients in Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma - Yahoo Finance
Why VF Corp Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket - Benzinga
Shuttle Pharmaceuticals Holdings Inc (SHPH-Q) QuotePress Release - The Globe and Mail
Shuttle Pharmaceuticals Shares Rise 63% on Drug-Study Site Update - MarketWatch
Shuttle Pharmaceuticals Advances Glioblastoma Clinical Trials - TipRanks
Shuttle Pharma Completes Clinical Trial Site Enrollment for - GlobeNewswire
Shuttle Pharma Completes Clinical Trial Site Enrollment for Phase 2 of Ropidoxuridine for Treatment of Patients with Glioblastoma - Marketscreener.com
Shuttle Pharmaceuticals to Present at ThinkEquity Conference - TipRanks
Shuttle Pharmaceuticals to Present at the 2024 ThinkEquity Conference on Wednesday, October 30, 2024 - GlobeNewswire
Shuttle Pharmaceuticals completes funding round, raises $790,000 By Investing.com - Investing.com Canada
Shuttle Pharmaceuticals completes funding round, raises $790,000 - Investing.com India
Shuttle Pharmaceuticals Holdings, Inc. announced that it expects to receive $1.3 million in funding - Marketscreener.com
Kingsoft Cloud Holdings Limited (NASDAQ:KC) Short Interest Update - Defense World
Office Properties Income Trust (NASDAQ:OPINL) Shares Up 3.9% – Here’s Why - Defense World
Munters Group AB (publ) (OTCMKTS:MMNNF) Stock Price Down 14.1% – Should You Sell? - Defense World
Shuttle Pharmaceuticals (NASDAQ:SHPH) Shares Up 7.2% – Should You Buy? - Defense World
Getlink: Shuttle Traffic in September 2024 - Yahoo Finance
SHPH stock touches 52-week low at $1.11 amid market challenges - Investing.com Australia
SHPH stock touches 52-week low at $1.11 amid market challenges By Investing.com - Investing.com South Africa
Stock Market Today: S&P 500 rides Nvidia-led tech surge to close higher - Investing.com
Union Pacific says FXE issuing some US-Mexico grain shuttle permits - Yahoo Finance
American Century Companies Inc. Lowers Stock Holdings in Paycom Software, Inc. (NYSE:PAYC) - Defense World
Ensign Peak Advisors Inc Sells 13,160 Shares of Owens Corning (NYSE:OC) - Defense World
Frank Rimerman Advisors LLC Takes $386,000 Position in Texas Roadhouse, Inc. (NASDAQ:TXRH) - Defense World
Skandinaviska Enskilda Banken AB publ Sells 2,013 Shares of Funko, Inc. (NASDAQ:FNKO) - Defense World
Thrivent Financial for Lutherans Purchases 32,464 Shares of Global X U.S. Infrastructure Development ETF (BATS:PAVE) - Defense World
Edison International (NYSE:EIX) PT Raised to $72.00 - Defense World
TransDigm Group Incorporated (NYSE:TDG) Stock Holdings Boosted by Zurich Insurance Group Ltd FI - Defense World
Shuttle Pharmaceuticals Holdings Inc (SHPH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.79%
0.15%
자본화:
|
볼륨(24시간):